Levina Kumar in Henderson, North Carolina

Home North Carolina Henderson

Levina Kumar has Nurse Practitioner as her primary medical specialty. Their primary office is: 943 W Andrews Ave in Henderson, North Carolina.

They're a part of the: Daymark Recovery Services Inc medical group which has around 73 members. You can call their office at 252-433-0061 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2018 (around 7 years of experience). They are listed as doing telehealth appointments.

Levina Kumar Office Phone and Directions

Levina Kumar
Daymark Recovery Services Inc
943 W Andrews Ave
Henderson, North Carolina 27536
252-433-0061

Patient Ratings
Please rate your experience with Levina Kumar below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 252-433-0061

Enter a starting address:

Healthcare Info for Levina Kumar

Medical School: Sorry, her university is not listed
Graduation Year: 2018
The Primary Medical Specialty for Levina Kumar is listed as: Nurse Practitioner
Approximate Years of Experience: 7
PAC (PECOS ID)#: 4789927955
NPI #: 1093276982
NPI Created On: 03/25/2019
NPI Last Updated Listed as: 09/01/2021
Primary Taxonomy Code: 363LP0808X
License Number:
5011613
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Established patient office or other outpatient, visit typically 25 minutes
Physician telephone patient service, 11-20 minutes of medical discussion
Physician telephone patient service, 21-30 minutes of medical discussion

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 837846543

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROLOGY

Name of Drug #1: INGREZZA

Open Associated Drug #1: 70370-2040-1